Page 1 | Search Results | Diabetes Care | American Diabetes Association

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Vaspin: A Novel Biomarker Linking Gluteofemoral Body Fat and Type 2 Diabetes Risk

Harry Hezhou Wang, Michael Chong, Nicolas Perrot, James Feiner, Sibylle Hess, Salim Yusuf, Hertzel Gerstein, Guillaume Paré, Marie Pigeyre

Diabetes Care 2024;47(2):259–266

https://doi.org/10.2337/dc23-1488

Published: 06 December 2023

View articletitled, Vaspin: A Novel Biomarker Linking Gluteofemoral Body Fat and Type 2 Diabetes Risk

Journal Articles

Contrasting Associations Between Diabetes and Cardiovascular Mortality Rates in Low-, Middle-, and High-Income Countries: Cohort Study Data From 143,567 Individuals in 21 Countries in the PURE Study

Diabetes Care 2020;43(12):3094–3101

https://doi.org/10.2337/dc20-0886

Published: 15 October 2020

View articletitled, Contrasting Associations Between Diabetes and Cardiovascular Mortality Rates in Low-, Middle-, and High-Income Countries: Cohort Study Data From 143,567 Individuals in 21 Countries in the PURE Study

Journal Articles

White Rice Intake and Incident Diabetes: A Study of 132,373 Participants in 21 Countries

Diabetes Care 2020;43(11):2643–2650

https://doi.org/10.2337/dc19-2335

Published: 01 September 2020

View articletitled, White Rice Intake and Incident Diabetes: A Study of 132,373 Participants in 21 Countries

Journal Articles

ACE and Type 2 Diabetes Risk: A Mendelian Randomization Study

Marie Pigeyre, Jennifer Sjaarda, Michael Chong, Sibylle Hess, Jackie Bosch, Salim Yusuf, Hertzel Gerstein, Guillaume Paré

Diabetes Care 2020;43(4):835–842

https://doi.org/10.2337/dc19-1973

Published: 04 February 2020

View articletitled, ACE and Type 2 Diabetes Risk: A Mendelian Randomization Study

Includes: Supplementary data

Journal Articles

Identification of Novel Causal Blood Biomarkers Linking Metabolically Favorable Adiposity With Type 2 Diabetes Risk

Marie Pigeyre, Jennifer Sjaarda, Shihong Mao, Michael Chong, Sibylle Hess, Salim Yusuf, Hertzel Gerstein, Guillaume Paré

Diabetes Care 2019;42(9):1800–1808

https://doi.org/10.2337/dc18-2444

Published: 24 June 2019

View articletitled, Identification of Novel Causal Blood Biomarkers Linking Metabolically Favorable Adiposity With Type 2 Diabetes Risk

Includes: Supplementary data

Journal Articles

Variations in Diabetes Prevalence in Low-, Middle-, and High-Income Countries: Results From the Prospective Urban and Rural Epidemiological Study

Diabetes Care 2016;39(5):780–787

https://doi.org/10.2337/dc15-2338

Published: 10 March 2016

View articletitled, Variations in Diabetes Prevalence in Low-, Middle-, and High-Income Countries: Results From the Prospective Urban and Rural Epidemiological Study

Includes: Supplementary data

Journal Articles

The Association of Basal Insulin Glargine and/or n-3 Fatty Acids With Incident Cancers in Patients With Dysglycemia

Louise Bordeleau, Natalia Yakubovich, Gilles R. Dagenais, Julio Rosenstock, Jeffrey Probstfield, Pan Chang Yu, Lars E. Ryden, Valdis Pirags, Giatgen A. Spinas, Kare I. Birkeland, Robert E. Ratner, Jose A. Marin-Neto, Matyas Keltai, Matthew C. Riddle, Jackie Bosch, Salim Yusuf, Hertzel C. Gerstein, for the ORIGIN Trial Investigators

Diabetes Care 2014;37(5):1360–1366

https://doi.org/10.2337/dc13-1468

Published: 10 April 2014

View articletitled, The Association of Basal Insulin Glargine and/or n-3 Fatty Acids With Incident Cancers in Patients With Dysglycemia

Journal Articles

Effect of Insulin Glargine and n-3FA on Carotid Intima-Media Thickness in People With Dysglycemia at High Risk for Cardiovascular Events: The Glucose Reduction and Atherosclerosis Continuing Evaluation Study (ORIGIN-GRACE)

Eva M. Lonn, MD, Jackie Bosch, MSC, Rafael Diaz, MD, Patricio Lopez-Jaramillo, MD, Ambady Ramachandran, MD, Nicolae Hâncu, MD, PHD, Markolf Hanefeld, MD, Henry Krum, MBBS, PHD, Lars Ryden, MD, PHD, Sandra Smith, RDMS, Matthew J. McQueen, MD, PHD, Leanne Dyal, MSC, Salim Yusuf, MD, DPHIL, Hertzel C. Gerstein, MD, for the GRACE and ORIGIN Investigators

Diabetes Care 2013;36(9):2466–2474

https://doi.org/10.2337/dc12-2129

Published: 13 August 2013

View articletitled, Effect of Insulin Glargine and n-3FA on Carotid Intima-Media Thickness in People With Dysglycemia at High Risk for Cardiovascular Events: The Glucose Reduction and Atherosclerosis Continuing Evaluation Study (ORIGIN-GRACE)

Includes: Supplementary data

Journal Articles

Genetic Information and the Prediction of Incident Type 2 Diabetes in a High-Risk Multiethnic Population: The EpiDREAM genetic study

Sonia S. Anand, MD, David Meyre, PHD, Guillaume Pare, MD, Swneke D. Bailey, PHD, Changchun Xie, PHD, Xiaohe Zhang, MSC, Alexandre Montpetit, PHD, Dipika Desai, MSC, Jackie Bosch, MSC, Viswanathan Mohan, MBBS, Rafael Diaz, MD, Matthew J. McQueen, MD, Heather J. Cordell, DPHIL, Bernard Keavney, MBBS, Salim Yusuf, MBBS, Daniel Gaudet, MD, Hertzel Gerstein, MD, James C. Engert, PHD, on behalf of the EpiDREAM Genetics Investigators

Diabetes Care 2013;36(9):2836–2842

https://doi.org/10.2337/dc12-2553

Published: 13 August 2013

View articletitled, Genetic Information and the Prediction of Incident Type 2 Diabetes in a High-Risk Multiethnic Population: The EpiDREAM genetic study

Includes: Supplementary data

Journal Articles

Screening for Dysglycemia in Overweight Youth Presenting for Weight Management

Katherine M. Morrison, MD, Liqin Xu, PHD, Mark Tarnopolsky, MD, Zaheera Yusuf, MSC, Stephanie A. Atkinson, PHD, Salim Yusuf, MBBS, DPHIL

Diabetes Care 2012;35(4):711–716

https://doi.org/10.2337/dc11-1659

Published: 13 March 2012

View articletitled, Screening for Dysglycemia in Overweight Youth Presenting for Weight Management

Includes: Supplementary data

Journal Articles

Piloting a Novel Algorithm for Glucose Control in the Coronary Care Unit: The RECREATE (REsearching Coronary REduction by Appropriately Targeting Euglycemia) trial

Kara A. Nerenberg, MD, Abhinav Goyal, MD, Denis Xavier, MBBS, Alben Sigamani, MBBS, Jennifer Ng, MSC, Shamir R. Mehta, MD, Rafael Díaz, MD, Mikhail Kosiborod, MD, Salim Yusuf, PHD, Hertzel C. Gerstein, MD, for the RECREATE Investigators

Diabetes Care 2012;35(1):19–24

https://doi.org/10.2337/dc11-0706

Published: 09 December 2011

View articletitled, Piloting a Novel Algorithm for Glucose Control in the Coronary Care Unit: The RECREATE (REsearching Coronary REduction by Appropriately Targeting Euglycemia) trial

Includes: Supplementary data

Journal Articles

Effects of Telmisartan on Glucose Levels in People at High Risk for Cardiovascular Disease but Free From Diabetes: The TRANSCEND study

Joshua I. Barzilay, MD, Peggy Gao, MSC, Lars Rydén, MD, Helmut Schumacher, PHD, Jeffrey Probstfield, MD, Patrick Commerford, MD, Antonio Dans, MD, Rafael Ferreira, MD, Mátyás Keltai, MD, Ernesto Paolasso, MD, Salim Yusuf, MD, Koon Teo, MD, on behalf of the TRANSCEND Investigators

Diabetes Care 2011;34(9):1902–1907

https://doi.org/10.2337/dc11-0545

Published: 19 August 2011

View articletitled, Effects of Telmisartan on Glucose Levels in People at High Risk for Cardiovascular Disease but Free From Diabetes: The TRANSCEND study

Includes: Supplementary data

Journal Articles

Variation at the NFATC2 Locus Increases the Risk of Thiazolidinedione-Induced Edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) Study

Swneke D. Bailey, BSC, Changchun Xie, PHD, Ron Do, MSC, Alexandre Montpetit, PHD, Rafael Diaz, MD, Viswanathan Mohan, MD, PHD, DSC, FRCP, Bernard Keavney, MD, FRCP, Salim Yusuf, MD, DPHIL, FRCPC, Hertzel C. Gerstein, MD, MSC, FRCPC, James C. Engert, PHD, Sonia Anand, MD, PHD, FRCPC, on behalf of the DREAM investigators

Diabetes Care 2010;33(10):2250–2253

https://doi.org/10.2337/dc10-0452

Published: 13 July 2010

View articletitled, Variation at the NFATC2 Locus Increases the Risk of Thiazolidinedione-Induced Edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) Study

Includes: Supplementary data

Journal Articles

Ethnic Variation in Adiponectin and Leptin Levels and Their Association With Adiposity and Insulin Resistance

Andrew Mente, PHD, Fahad Razak, BENG, MSC, Stefan Blankenberg, MD, Vlad Vuksan, PHD, A. Darlene Davis, RN, Ruby Miller, RN, Koon Teo, MBBCH, PHD, Hertzel Gerstein, MD, MSC, Arya M. Sharma, MD, PHD, Salim Yusuf, MBBS, DPHIL, Sonia S. Anand, MD, PHD, for the Study of Health Assessment and Risk Evaluation (SHARE) and SHARE in Aboriginal Peoples (SHARE-AP) Investigators

Diabetes Care 2010;33(7):1629–1634

https://doi.org/10.2337/dc09-1392

Published: 22 April 2010

View articletitled, Ethnic Variation in Adiponectin and Leptin Levels and Their Association With Adiposity and Insulin Resistance

Includes: Supplementary data

Journal Articles

Effect of Rosiglitazone and Ramipril on β-Cell Function in People With Impaired Glucose Tolerance or Impaired Fasting Glucose: The DREAM trial

Anthony J. Hanley, PHD, Bernard Zinman, MD, Patrick Sheridan, PHD, Salim Yusuf, MD, Hertzel C. Gerstein, MD, for the Diabetes Reduction Assessment With Ramipril and Rosiglitazone Medication (DREAM) Investigators

Diabetes Care 2010;33(3):608–613

https://doi.org/10.2337/dc09-1579

Published: 15 December 2009

View articletitled, Effect of Rosiglitazone and Ramipril on β-Cell Function in People With Impaired Glucose Tolerance or Impaired Fasting Glucose: The DREAM trial

Includes: Supplementary data

Journal Articles

Predictors of Development of Diabetes in Patients With Chronic Heart Failure in the Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM) Program

David Preiss, MRCP, Sofia Zetterstrand, PHD, John J.V. McMurray, MD, Jan Östergren, MD, Eric L. Michelson, MD, Christopher B. Granger, MD, Salim Yusuf, MB BS, DPHIL, Karl Swedberg, MD, PHD, Marc A. Pfeffer, MD, PHD, Hertzel C. Gerstein, MD, Naveed Sattar, PHD, for the Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity Investigators

Diabetes Care 2009;32(5):915–920

https://doi.org/10.2337/dc08-1709

Published: 05 February 2009

View articletitled, Predictors of Development of Diabetes in Patients With Chronic Heart Failure in the Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM) Program

Journal Articles

Dysglycemia and a History of Reproductive Risk Factors

Sarah D. McDonald, MD, MSC, Salim Yusuf, MD, DPHIL, Patrick Sheridan, MSC, Sonia S. Anand, MD, PHD, Hertzel C. Gerstein, MD, MSC, for the DREAM Trial Investigators

Diabetes Care 2008;31(8):1635–1638

https://doi.org/10.2337/dc08-0621

Published: 01 August 2008

View articletitled, Dysglycemia and a History of Reproductive Risk Factors

Journal Articles

Diagnostic Strategies to Detect Glucose Intolerance in a Multiethnic Population

Sonia S. Anand, MD, MSC, Fahad Razak, BASC, Vlad Vuksan, PHD, Hertzel C. Gerstein, MD, MSC, Klas Malmberg, MD, PHD, Qilong Yi, MSC, Koon K. Teo, MB, PHD, Salim Yusuf, FRCP, DPHIL

Diabetes Care 2003;26(2):290–296

https://doi.org/10.2337/diacare.26.2.290

Published: 01 February 2003

View articletitled, Diagnostic Strategies to Detect Glucose Intolerance in a Multiethnic Population

Journal Articles

The Relationship Between Dysglycemia and Atherosclerosis in South Asian, Chinese, and European Individuals in Canada: A randomly sampled cross-sectional study

Hertzel C. Gerstein, MD, MSC, Sonia Anand, MD, MSC, Qi Long Yi, MSC, Vladimir Vuksan, PHD, Eva Lonn, MD, MSC, Koon Teo, MBBCH, Klas Malmberg, MD, PHD, Matthew McQueen, MBCHB, Salim Yusuf, MD, MBBS, DPHIL, For the SHARE Investigators*

Diabetes Care 2003;26(1):144–149

https://doi.org/10.2337/diacare.26.1.144

Published: 01 January 2003

View articletitled, The Relationship Between Dysglycemia and Atherosclerosis in South Asian, Chinese, and European Individuals in Canada: A randomly sampled cross-sectional study

Journal Articles

Effects of Vitamin E on Cardiovascular and Microvascular Outcomes in High-Risk Patients With Diabetes: Results of the HOPE Study and MICRO-HOPE Substudy

Eva Lonn, MD MSC, Salim Yusuf, MBBS, DPHIL, Byrcon Hoogwerf, MD, Janice Pogue, MSC, Qilong Yi, PHD, Bernard Zinman, MD, Jackie Bosch, MSC, Gilles Dagenais, MD, Johannes F.E. Mann, MD, Hertzel C. Gerstein, MD, MSC, on behalf of the Heart Outcomes Prevention Evaluation (HOPE) Investigators

Diabetes Care 2002;25(11):1919–1927

https://doi.org/10.2337/diacare.25.11.1919

Published: 01 November 2002

View articletitled, Effects of Vitamin E on Cardiovascular and Microvascular Outcomes in High-Risk Patients With Diabetes: Results of the HOPE Study and MICRO-HOPE Substudy

Update search

NARROW

Format

Journal

Article Type

Topics

Subjects

Issue Section

Date

Availability

Vaspin: A Novel Biomarker Linking Gluteofemoral Body Fat and Type 2 Diabetes Risk

Contrasting Associations Between Diabetes and Cardiovascular Mortality Rates in Low-, Middle-, and High-Income Countries: Cohort Study Data From 143,567 Individuals in 21 Countries in the PURE Study

White Rice Intake and Incident Diabetes: A Study of 132,373 Participants in 21 Countries

ACE and Type 2 Diabetes Risk: A Mendelian Randomization Study

Identification of Novel Causal Blood Biomarkers Linking Metabolically Favorable Adiposity With Type 2 Diabetes Risk

Variations in Diabetes Prevalence in Low-, Middle-, and High-Income Countries: Results From the Prospective Urban and Rural Epidemiological Study

The Association of Basal Insulin Glargine and/or n-3 Fatty Acids With Incident Cancers in Patients With Dysglycemia

Effect of Insulin Glargine and n-3FA on Carotid Intima-Media Thickness in People With Dysglycemia at High Risk for Cardiovascular Events: The Glucose Reduction and Atherosclerosis Continuing Evaluation Study (ORIGIN-GRACE)

Genetic Information and the Prediction of Incident Type 2 Diabetes in a High-Risk Multiethnic Population: The EpiDREAM genetic study

Screening for Dysglycemia in Overweight Youth Presenting for Weight Management

Piloting a Novel Algorithm for Glucose Control in the Coronary Care Unit: The RECREATE (REsearching Coronary REduction by Appropriately Targeting Euglycemia) trial

Effects of Telmisartan on Glucose Levels in People at High Risk for Cardiovascular Disease but Free From Diabetes: The TRANSCEND study

Variation at the NFATC2 Locus Increases the Risk of Thiazolidinedione-Induced Edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) Study

Ethnic Variation in Adiponectin and Leptin Levels and Their Association With Adiposity and Insulin Resistance

Effect of Rosiglitazone and Ramipril on β-Cell Function in People With Impaired Glucose Tolerance or Impaired Fasting Glucose: The DREAM trial

Predictors of Development of Diabetes in Patients With Chronic Heart Failure in the Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM) Program

Dysglycemia and a History of Reproductive Risk Factors

Diagnostic Strategies to Detect Glucose Intolerance in a Multiethnic Population

The Relationship Between Dysglycemia and Atherosclerosis in South Asian, Chinese, and European Individuals in Canada: A randomly sampled cross-sectional study

Effects of Vitamin E on Cardiovascular and Microvascular Outcomes in High-Risk Patients With Diabetes: Results of the HOPE Study and MICRO-HOPE Substudy

Email alerts

Journals

Books

Clinical Compendia

News

Podcasts

Other

About

Resources

Update search

Email alerts

Journals

Books

Clinical Compendia

News

Podcasts

Other

About

Resources

This Feature Is Available To Subscribers Only